Columbia University Medical Center   discover care educate lead
HDNY.org hdsa center of excellence    
at the NY state psychiatric institute

If you notice any problems with the website, please email site editor.

Publications

Clinical Trials - ABSTRACTS

  1. Huntington Study Group (Marshall FJ, primary author). Safety and tolerability of the free-radical scavenger OPC-14117 in Huntington's disease. Mov Disord 1996;11:59.
  2. Huntington Study Group (K Kieburtz, presenter). Placebo-Controlled Trial of Creatine in Huntington’s Disease. Neurol 2001;56:A386.
  3. Huntington Study Group (FJ Marshall, presenter). Riluzole dosing in Huntington's Disease (RID-HD): Results of an 8-week double-blind, placebo-controlled, multi-center study by the Huntington Study Group. Proceedings of the 19th International Meeting of the World Federation of Neurology Research Group on Huntington’s Disease, August 25-28, 2001, Copenhagen, Denmark. Publ-ication of the Panum Institute, p. 29-30, 2001.
  4. Huntington Study Group (M. Cudkowicz, primary author). Minocycline safety and tolerability in Huntington’s disease. Mov Disord 2003;18:1084.
  5. Frank SA, Marshall F, Plumb S, Oakes D, Shoulson I, Kieburtz K, CARE-HD Investigators of the Huntington Study Group. Functional decline due to chorea in Huntington’s disease. Neurol 2004;62(Suppl 5):A204.
  6. Huntington Study Group (F.J. Marshall, presenter). A Randomized, Double-Blind, Placebo-Controlled Study of Tetrabenazine in Patients with Huntington’s Disease. Mov Disord 2004;19:1122.
  7. Frank S, Ondo W, Hunter C, Marshall F, Walker F, Eberly S, Factor S, Fahn S, Hunt V, Oakes D, Plumb S, Shinaman A, Shoulson I, Zhao H, Jankovic J. A randomized, double-blind, placebo-controlled, staggered withdrawal study in patients with Huntington’s disease treated with tetrabenazine. Mov Disord 2005;20(9):1244.
  8. Hyson, C. for the Huntington Study Group. Pre-2CARE: a dosage ranging trial of coenzyme Q10 in Huntington’s Disease and in healthy subjects. Hereditary Diseases Foundation Annual Symposium, August 2004.
  9. Hyson HC & the Huntington Study Group, QuBE: A bioequivalence study of coenzyme Q10 in healthy subjects. Movement Disorders Society Meeting. 2005.
  10. Marshall FJ, Eberly S, Frank S, Oakes D and the Huntington Study Group/TETRA-HD Investigators. Predictors of response to tetrabenazine in Huntington’s disease. Mov Disord 2006;21(9):1547.
  11. Frank SA on behalf of the Huntington Study Group TETRA-HD Investigators. An open label study of tetrabenazine as anti-chorea therapy in Huntington disease. Neuro 2007;68(Suppl 1):A365.
 
 

Copyright 2000-2009 HDNY.ORG : At NY State Psychiatric Institute
Columbia University Medical Center : Department of Neurology : Last updated 27-Jun-2009